WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced that Gregory L. Summe, the Company’s Chairman and CEO, has adopted a prearranged trading plan in accordance with Rule 10b5-1 under the Securities and Exchange Act of 1934, as well as the Company’s policies with respect to sales of shares held by insiders. Mr. Summe has adopted a plan for the exercise and subsequent share sale of 900,000 options, which were granted in January 1999 and expire in January 2009. After these sales, Mr. Summe would hold shares and options totaling over 4,400,000 shares.
